John P Hirdes1, Dinnus H Frijters, Gary F Teare. 1. Department of Health Studies and Gerontology, University of Waterloo, Waterloo, Ontario, Canada. hirdes@uwaterloo.ca
Abstract
OBJECTIVES: To develop a scale predicting mortality and other adverse outcomes associated with frailty. DESIGN: Observational study based on Minimum Data Set (MDS) 2.0 and mortality data. SETTING: Ontario chronic hospitals. PARTICIPANTS: All chronic hospital patients (N = 28,495) assessed with the MDS 2.0 after mandatory implementation in July 1996 followed until May 1999. MEASUREMENTS: MDS 2.0 assessments done as part of normal practice mainly by registered nurses or multidisciplinary teams in a chronic hospital. Mortality data are available from the accompanying discharge tracking form. RESULTS: The MDS-Changes in Health, End-stage disease and Symptoms and Signs (CHESS) score is a composite measure addressing changes in health, end-stage disease, and symptoms and signs of medical problems. It is a strong predictor of mortality (P <.0001) independent of the effects of age, sex, activities of daily living impairment, cognition, and do-not-resuscitate orders. It is also strongly associated with physician activity, complex medical procedures, and pain (P <.001 for each dependent variable). CONCLUSIONS: The CHESS score provides a useful new MDS-based test to predict mortality and to measure instability in health as a clinical outcome.
OBJECTIVES: To develop a scale predicting mortality and other adverse outcomes associated with frailty. DESIGN: Observational study based on Minimum Data Set (MDS) 2.0 and mortality data. SETTING: Ontario chronic hospitals. PARTICIPANTS: All chronic hospital patients (N = 28,495) assessed with the MDS 2.0 after mandatory implementation in July 1996 followed until May 1999. MEASUREMENTS: MDS 2.0 assessments done as part of normal practice mainly by registered nurses or multidisciplinary teams in a chronic hospital. Mortality data are available from the accompanying discharge tracking form. RESULTS: The MDS-Changes in Health, End-stage disease and Symptoms and Signs (CHESS) score is a composite measure addressing changes in health, end-stage disease, and symptoms and signs of medical problems. It is a strong predictor of mortality (P <.0001) independent of the effects of age, sex, activities of daily living impairment, cognition, and do-not-resuscitate orders. It is also strongly associated with physician activity, complex medical procedures, and pain (P <.001 for each dependent variable). CONCLUSIONS: The CHESS score provides a useful new MDS-based test to predict mortality and to measure instability in health as a clinical outcome.
Authors: Micaela Jantzi; Amy C Maher; George Ioannidis; John P Hirdes; Lora M Giangregorio; Alexandra Papaioannou Journal: Age Ageing Date: 2014-11-14 Impact factor: 10.668
Authors: Charles D Phillips; Scott Holan; Michael Sherman; Malgorzata Leyk Williams; Catherine Hawes Journal: Am J Public Health Date: 2004-10 Impact factor: 9.308
Authors: Jenny X Zhang; Jennifer D Walker; Walter P Wodchis; David B Hogan; David H Feeny; Colleen J Maxwell Journal: Qual Life Res Date: 2006-06-22 Impact factor: 4.147
Authors: Shelly A Vik; David B Hogan; Scott B Patten; Jeffrey A Johnson; Lori Romonko-Slack; Colleen J Maxwell Journal: Drugs Aging Date: 2006 Impact factor: 3.923
Authors: John P Hirdes; Dawn M Dalby; R Knight Steel; G Iain Carpenter; Roberto Bernabei; John N Morris; Brant E Fries Journal: Can J Public Health Date: 2006 Jul-Aug